Drug Shortage Report for JAMP CANDESARTAN-HCT
Report ID | 211765 |
Drug Identification Number | 02473240 |
Brand name | JAMP CANDESARTAN-HCT |
Common or Proper name | Candesartan Cilexetil and Hydrochlorothiazide Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE |
Strength(s) | 16MG 12.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-11-27 |
Estimated end date | 2024-07-15 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-17 |
Company comments | Allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2024-04-17 | French | Compare |
v11 | 2024-04-17 | English | Compare |
v10 | 2024-03-19 | French | Compare |
v9 | 2024-03-19 | English | Compare |
v8 | 2024-03-11 | French | Compare |
v7 | 2024-03-11 | English | Compare |
v6 | 2024-02-06 | French | Compare |
v5 | 2024-02-06 | English | Compare |
v4 | 2023-12-30 | French | Compare |
v3 | 2023-12-30 | English | Compare |
v2 | 2023-11-28 | French | Compare |
v1 | 2023-11-28 | English | Compare |
Showing 1 to 12 of 12